Susquehanna International Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,700
Closed -$55.4K 13854
2025
Q4
$55.4K Buy
+10,700
New +$51.8K ﹤0.01% 11717
2024
Q4
Sell
-22,700
Closed -$64.9K 12929
2024
Q3
$64.9K Sell
22,700
-4,800
-17% -$13.5K ﹤0.01% 11276
2024
Q2
$77K Buy
27,500
+6,300
+30% +$16.9K ﹤0.01% 11194
2024
Q1
$60.2K Sell
21,200
-3,000
-12% -$10.2K ﹤0.01% 11480
2023
Q4
$99K Buy
24,200
+7,100
+42% +$19.9K ﹤0.01% 11340
2023
Q3
$54.4K Sell
17,100
-89,000
-84% -$283K ﹤0.01% 11263
2023
Q2
$352K Buy
106,100
+800
+0.8% +$2.36K ﹤0.01% 9110
2023
Q1
$224K Buy
+105,300
New +$260K ﹤0.01% 10347
2022
Q3
Sell
-20,500
Closed -$100K 13867
2022
Q2
$100K Sell
20,500
-11,200
-35% -$68.9K ﹤0.01% 11480
2022
Q1
$242K Sell
31,700
-77,500
-71% -$600K ﹤0.01% 10783
2021
Q4
$1.01M Buy
109,200
+66,000
+153% +$701K ﹤0.01% 7271
2021
Q3
$615K Buy
43,200
+19,400
+82% +$301K ﹤0.01% 8856
2021
Q2
$396K Buy
+23,800
New +$444K ﹤0.01% 10163

Other funds holding ORGO

Susquehanna International Group's ORGO Position: Q1 2026 in Review

Susquehanna International Group reduced its Organogenesis Holdings (ORGO) stake by 58% in Q1 2026, selling an estimated $135K and leaving 28,307 shares worth $67.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12533.

Susquehanna International Group first reported a position in ORGO in Q1 2019 and has held it in 20 quarters since. The position peaked at $2.63M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Susquehanna International Group held 28,307 shares of Organogenesis Holdings worth $67.1K as of Q1 2026.
  • Susquehanna International Group sold 39,002 Organogenesis Holdings shares in Q1 2026, an estimated $135K.
  • Organogenesis Holdings made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12533 holding.
  • Susquehanna International Group first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 20 quarters since.
  • Susquehanna International Group's Organogenesis Holdings position peaked at $2.63M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.